Package Insert, Cephulac®, Merrell-National Laboratories, August 1975.
2.
HodgsonJ.: Effect of Lactulose on Rabbits Fed on a Low Residue Diet, Am. J. Gastroenterol.64: 115–121 (Aug.) 1975.
3.
LevineM. M.HornickR. B.: Lactulose Therapy in Shigella Carrier State and Acute Dysentery, Antimicrob. Agents Chemother.8: 581–584 (Nov.) 1975.
4.
PorterN.: The Use of Lactulose in Post-Hemorrhoidectomy Patients, Br. J. Clin. Pract.29: 235–236 (Sept.) 1975.
5.
ProutB. J.DattaS. B.WilsonT. S.: Colonic Retention of Barium in the Elderly After Barium-Meal Examination and Its Treatment with Lactulose, Br. Med. J.4: 530–533 (Dec. 2) 1972.
6.
LosnerI.: Lactulose — A Clinical Study in a Chronically Constipated Geriatric Population, Clin. Med.76: 24–29 (Dec.) 1969.
7.
WatsonJ. S.EbertW. R.: Lactulose—A New Bowel Regulator, Clin. Med.76: 24–26 (July) 1969.
8.
ConnollyP.HughesI. W.RyanG.: Comparison of ‘Duphulac®’ and Irritant' Laxatives During and After Treatment of Chronic Constipation: A Preliminary Study, Curr. Med. Res. Opin.2: 620–625, 1975.
9.
RyanD.WilsonA.MuirT. S.JudgeT.: The Reduction of Fecal Incontinence by the Use of ‘Duphulac®' in Geriatric Patients, Curr. Med. Res. Opin.2: 329–333, 1974.
10.
CasparisA. Wesselius-DeBraadbaartS.Bergh-BohlkenG. E.MimicaM.: Treatment of Chronic Constipation with Lactulose Syrup—Results of a Double-Blind Study, Gut9: 84–86 (Feb.) 1968.
11.
WilsonA.MuirT. S.: Geriatric Fecal Incontinence—A Drug Trial Conducted by Nurses, Nurs. Mirror140: 50–52 (Apr. 17) 1975.
12.
HedgerR. W.IngT. S.WangF.KovithavongsT.: Lactulose Therapy in Chronic Renal Failure (Abstr.), J. Lab. Clin. Med.78: 1015 (Dec.) 1971.
13.
DahlquistA.GryboskiJ.: Inability of the Human Small Intestine to Hydrolyze Lactulose, Biochem. Biophys. Acta110: 635–636, 1965.
14.
BircherJ.HaemmerliU. P.WilliamR.: Lactulose in the Treatment of Portal-Systemic Encephalopathy-Report of a Symposium, Gastroenterology58: 595–597 (Apr.) 1970.
15.
AveryG. S.DaviesE. F.BrogdenR. N.: Lactulose—A Review of Its Therapeutic and Pharmacological Properties with Particular Reference to Ammonia Metabolism and Its Mode of Action in Portal Systemic Encephalopathy—Report of a Symposium, Drues4: 7–48, 1972.
HaemmerliU. P.KistlerH.AmmannR.MarthalerT.SemenzaG.AuricchioS.PraderA.: Acquired Milk Intolerance in the Adult Caused by Lactose Malabsorption Due to a Selective Deficiency of Intestinal Lactase Activity, Am. J. Med.38: 7–30 (Jan.) 1965.
18.
WelshJ. D.LangdonD. E.: Lactose to Treat Hepatic Encephalopathy in a Patient with Lactose Malabsorption, N. Engl. J. Med.286: 436 (Feb. 24) 1972.
19.
FischerJ. E.: Hepatic Coma in Cirrhosis, Portal Hypertension and Following Portacaval Shunt, Arch. Surg.108: 325–336 (Mar.) 1974.
20.
BrownH.TreyC.McDermottW. V.: Encephalopathy After Portacaval Shunting Managed with Lactulose, Am. J. Surg.119: 132–137 (Feb.) 1970.
21.
BondJ. H.LevittM. D.: Investigation of Small Bowel Transit Time in Man Utilizing Pulmonary Hydrogen Measurements, J. Lab. Clin. Med.85: 546–555 (Apr.) 1975.
22.
BircherJ.: The Many Effects of Lactulose—A Rational Approach to Its Therapeutic Use, Drugs4: 1–3, 1972.
23.
BircherJ.HaemmerliU. P.Scollo-LavizzariG.HoffmanK.: Treatment of Chronic Portal Systemic Encephalopathy with Lactulose, Am. J. Med.51: 148–159 (Aug.) 1971.
24.
ElkingtonS. G.FlochM. H.ConnH. O.: Lactulose in the Treatment of Chronic Portal Systemic Encephalopathy, N. Engl. J. Med.281: 408–412 (Aug. 21) 1969.
25.
ZeeganR.DrinkwaterJ. E.FentonJ. C. B.VinceA.DawsonA. M.: Some Observations on the Effects of Treatment with Lactulose on Patients with Chronic Hepatic Encephalopathy, Q. J. Med.39: 245–263 (Apr.) 1970.
26.
BircherJ.MullerJ.GuggenheimP.HaemmerliU. P.: Treatment of Chronic Portal Systemic Encephalopathy with Lactulose, Lancet1: 890–893 (Apr. 23) 1966.
27.
SimmonsF.GoldsteinH.BoyleJ. D.: A Controlled Clinical Trial of Lactulose in Hepatic Encephalopathy, Gastroenterology59: 827–832 (Dec.) 1970.
28.
RodgersJ. B.KileyJ. E.BalintJ. A.: Comparison of Results of Long-Term Treatment of Chronic Hepatic Encephalopathy with Lactulose and Sorbitol, Am. J. Gastroenterol.60: 459–465 (Nov.) 1973.
29.
BrownH.TreyC.McDermottW. V.: Lactulose Treatment of Hepatic Encephalopathy in Outpatients, Arch. Surg.102: 25–27 (Jan.) 1971.
30.
ConnH. O.FlochM. H.: Effects of Lactulose and Lactobacillus Acidophilus on the Fecal Flora, Am. J. Clin. Nutr.23: 1588–1594 (Dec.) 1970.
31.
VinceA.ZeeganR.DrinkwaterJ. E.O'GradyF.DawsonA. M.: The Effect of Lactulose on the Fecal Flora of Patients with Hepatic Encephalopathy, J. Med. Microbiol.7: 163–168, 1974.
32.
KerschE. S.RifkinH.: Lactulose Enemas, Ann. Intern. Med.78: 81–84 (Jan.) 1973.
33.
PriceJ. B.SchwartzG. F.AbdolghaderM.BrittonR. C.VoorheesA. B.: Mechanism and Clinical Significance of Intestinal Ammonia Transport, Surg. Forum18: 331–333, 1967.
34.
HaemmerliU. P.BircherJ.: Influence of Lactulose Treatment on Non-ionic Diffusion of Ammonia in the Dog Colon (Abstr.)Gastroenterology56: 1163 (June) 1969.
35.
CastellD. O.MooreE. W.: Ammonia Absorption from the Human Colon, Gastroenterology60: 33–42 (Jan.) 1971.
36.
AgostiniL.DownP. F.MurisonJ.WrongO. M.: Faecal Ammonia and pH During Lactulose Administration in Man-Comparison with Other Cathartics, Gut13: 859–866 (Nov.) 1972.
37.
HubelK. A.: Lactulose Works, But Why?, Gastroenterology65: 349–351 (Aug.) 1973.
38.
VinceA.DawsonA. M.ParkN.O'GradyF.: Ammonia Production by Intestinal Bacteria, Gut14: 171–177 (Mar.) 1973.
39.
CarlinH. S.: Pharmacy Problem Clinic, Hosp. Top.15: 30–32 (July) 1973.
JamesI. M.GarassiniM.: Effect of Lactulose on Cerebral Metabolism in Patients with Chronic Portosystemic Encephalopathy, Gut12: 702–704 (Sept.) 1971.
44.
HislopI. G.RatnaikeR. N.O'HalloranM. W.PascoeN. P.: Lactulose Lowers Arterial Ammonia in Hepatic Failure, Am. J. Gastroenterol.58: 626–632 (Dec.) 1972.
45.
KardelT.OlsenP. Z.StigsbyB.TønnesenK.: Hepatic Encephalopathy Evaluated by Automatic Period Analysis of the Electroencephalogram During Lactulose Treatment, Acta Med. Scand.192: 493–498, 1972.
46.
MaM. H.McLeodJ. G.BlackburnC. R. B.: Long-Term Treatment of Portal Systemic Encephalopathy with Lactulose, Aust. Ann. Med.18: 117–123, 1969.
BrownH.McDermottW. V.: Lactulose Treatment of Hepatic Encephalopathy in Outpatients (Abstr.)J. Am. Med. Assoc.212: 865 (May 4) 1970.
49.
FungW. P.KhooO. T.: Treatment of Chronic Hepatic Encephalopathy with Lactulose, Med. J. Aust.2: 160–163 (July 27) 1968.
50.
SiebnerH.MissmahlH. P.: The Treatment of Hepatoportal Encephalopathy with Lactulose, Germ. Med. Monthly15: 529–533 (Sept.) 1970.
51.
FesselJ. M.ConnH. O.: Lactulose in the Treatment of Acute Hepatic Encephalopathy, Am. J. Med. Sci.266: 103–110, 1973.
52.
ConnH. O.LeevyC. M.MaddreyW. C.RodgersJ. B.SeefL.VlachevicZ. R.: Lactulose in the Treatment of Chronic Portalsystemic Encephalopathy—A Prospective Double-Blind Cooperative Comparison of Lactulose with Neomycin (Abstr.)Gastroenterology67: 784, 1974.
53.
ConnH. O.: Interactions of Lactulose and Neomycin, Drugs4: 4–6, 1972.
54.
PirotteJ.GuffensJ. M.DevosJ.: Comparative Study of Basal Arterial Ammonemia and of Orally-Induced Hyper-ammonemia in Chronic Portal Systemic Encephalopathy, Treated with Neomycin, Lactulose, and an Association of Neomycin and Lactulose, Digestion10: 435–444, 1974.